Phocas Financial Corp. Mirum Pharmaceuticals, Inc. Transaction History
Phocas Financial Corp.
- $25 Billion
- Q2 2024
A detailed history of Phocas Financial Corp. transactions in Mirum Pharmaceuticals, Inc. stock. As of the latest transaction made, Phocas Financial Corp. holds 60,399 shares of MIRM stock, worth $2.35 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
60,399
Previous 61,536
1.85%
Holding current value
$2.35 Million
Previous $1.55 Million
33.57%
% of portfolio
0.01%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding MIRM
# of Institutions
172Shares Held
54.2MCall Options Held
96.1KPut Options Held
54.8K-
Frazier Life Sciences Management, L.P. Menlo Park, CA6.5MShares$252 Million13.09% of portfolio
-
Janus Henderson Group PLC London, X04.99MShares$194 Million0.09% of portfolio
-
Bvf Inc San Francisco, CA4.37MShares$170 Million4.57% of portfolio
-
Eventide Asset Management, LLC Boston, MA3.61MShares$140 Million2.18% of portfolio
-
Black Rock Inc. New York, NY3.24MShares$126 Million0.0% of portfolio
About Mirum Pharmaceuticals, Inc.
- Ticker MIRM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,751,700
- Market Cap $1.43B
- Description
- Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...